STAb Therapeutics appoints Carolina Pola as Chief Executive Officer
STAb Therapeutics, a biotechnology company that develops novel immune redirecting cell therapies for cancer, announces that Dr. Carolina Pola has been appointed as CEO of the Company. Dr. Pola brings a biobusiness perspective and expertise to STAb Therapeutics to develop and deploy the strategic plan for the growth of the Company. She has developed an …
STAb Therapeutics appoints Carolina Pola as Chief Executive Officer Leer más »